Publication | Closed Access
A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma
46
Citations
35
References
2020
Year
Radiation TherapyMolecular RadiotherapyMedicinePhase Iia TrialRadiopharmaceutical TherapyMri-guided Radiation TherapyPrimary RefractoryOncologyRadiation OncologyNuclear MedicineCancer ResearchRadiologyHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1